With our advanced formulations, you can trust that you are choosing a product that aligns with your health goals
The relevant UK legislative backdrop is the Human Medicines Regulations 2012, which governs the authorisation, supply, and labelling of licensed medicines
You must discard it immediately
BioNxt Solutions announces the launch of a feasibility study for the development of an oral dissolvable film (ODF) formulation of Semaglutide, a GLP-1 receptor agonist currently marketed globally under the brand names Ozempic, Rybelsus, and Wegovy
This is supported by many reports of Ozempic being misused by non-diabetic individuals for weight loss, although it is not approved for that purpose in Malaysia. Mr Amrahi warned against using drugs for unapproved purposes without medical supervision, emphasising that potential side effects of Ozempic include hypoglycaemia or low blood sugar, which could be life-threatening